FEMSelect Ltd., a women-led company developing innovative technologies to make a lasting impact on women's health, today announced positive results from a large six-month safety and outcome study of ...
NEWARK, Del., Sept. 13, 2022 /PRNewswire/ -- FEMSelect, the developer of EnPlace®, a minimally invasive, meshless approach to pelvic floor ligament fixation, reported positive results in a four-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback